Inhalation CDMO Industry Outlook 2025-2029: Market Set to Cross $2.84 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Inhalation CDMO Market Size By 2025?
In recent times, the market size of the inhalation CDMO has shown considerable growth. The market, valued at $2.08 billion in 2024, is projected to increase to $2.2 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.0%. Factors contributing to this growth during the historical period include an increase in respiratory disorders, a surge in personalized medicine demand, an uptick in pharmaceutical company outsourcing, and the expansion of the biopharmaceutical industry.

How Big Is the Inhalation CDMO Market Size Expected to Grow by 2029?
The size of the inhalation CDMO market is predicted to witness substantial growth over the next few years, reaching $2.84 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 6.5%. This projected increase, during the forecast period, can be credited to elements such as the emphasis on precision medicine and targeted therapies, swift escalation of biopharmaceutical inhalation therapies, attention on patient-centric solutions, global market expansion, and opportunities in up-and-coming markets, along with regulatory support for the development of inhalation drugs. Notable emerging trends expected during the forecast period embrace the rising demand for digital health solutions, biologic inhalation therapies, focus on eco-friendly inhaler technologies, incorporation of artificial intelligence (AI) and machine learning, as well as collaborations and partnerships.

View the full report here:
https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

Which Key Market Drivers Powering Inhalation CDMO Market Expansion and Growth?
As the number of respiratory conditions continues to rise, the inhalation CDMO market is slated for a significant expansion. These respiratory conditions encompass a series of health issues that affect the body's breathing system, including all organs and parts involved in the breathing process. Inhalation CDMOs are crucial in creating and manufacturing medicinal products for treating these health ailments, thanks to their skills in formulating and transporting medication to the lungs. They provide pharmaceutical firms with the much-needed specialized knowledge, resources, and structure to develop novel inhalation treatments. As an illustration, the Australian Bureau of Statistics, a government agency in Australia, revealed that 34% of Australians - about 8.5 million people- indicated they had chronic respiratory problems. These include an estimated 11% of the population, around 2.8 million people suffering from asthma, and 2.5% (roughly 638,000 individuals) dealing with COPD. Consequently, the growing incidence of respiratory problems is fuelling the inhalation CDMO market's expansion.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp

Which Emerging Trends Are Transforming the Inhalation CDMO Market in 2025?
Leading businesses in the inhalation CDMO sector are opting for a strategic partnership model to offer focused drug development and delivery. A strategic partnership is a long-term cooperation between two or more companies that collaboratively works to achieve common goals. For example, in May 2023, Hovione, a Contract Development and Manufacturing Organization based in Portugal, established a partnership with H&T Presspart, a UK-based provider of high-precision plastic and metal components for the pharmaceutical sector, for the development of Presspart's Sunrise Capsule-based Dry Powder Inhaler platform. The primary objective of this partnership is to create new technologies capable of delivering increased drug doses and enhancing the effectiveness of drug delivery to the lungs.

What Are the Emerging Segments in the Inhalation CDMO Market?
The inhalation cdmo market covered in this report is segmented -

1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler
2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
3) By Technology: Manual Inhalers (SMI), Digital Inhalers
4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users

Subsegments:
1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs
2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs
3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers
4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13864&type=smp

Who Are the Global Leaders in the Inhalation CDMO Market?
Major companies operating in the inhalation CDMO market report are Pfizer Inc., Merck KGaA, Baxter's BioPharma Solutions, Lonza Group AG, Catalent Inc., AptarGroup Inc., Samsung Biologics Co. Ltd., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, Cambrex Corporation, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Formosa Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Dipharma Francis Srl, Copley Scientific

Which are the Top Profitable Regional Markets for the Inhalation CDMO Industry?
North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the inhalation CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13864

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.